Publications by authors named "Suzanne Carreira"

53Publications

Genetic Analysis of Circulating Tumour Cells.

Recent Results Cancer Res 2020 ;215:57-76

The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-030-26439-0_3DOI Listing
October 2019

PARP Inhibitors for Advanced Prostate Cancer: Validating Predictive Biomarkers.

Eur Urol 2019 10 4;76(4):459-460. Epub 2019 Apr 4.

The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.03.029DOI Listing
October 2019

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

N Engl J Med 2016 Aug 6;375(5):443-53. Epub 2016 Jul 6.

From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1603144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986616PMC
August 2016

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

N Engl J Med 2015 Oct;373(18):1697-708

From the Institute of Cancer Research (J.M., S.C., S.S., S.M., H.M., R.P.-L., D.N.R., A.O., N.T., G.B., N.P., P.F., A.G., I.F., C.P., G.S., D.B., J.G., Z.Z., C.T.W., R.F., R.R., B.E., G.F., D. Roda, W.Y., R.B., H.P., R.A., A.S., R.E., G.A., C.J.L., A.A., E.H., J.S.B.), the Royal Marsden NHS Foundation Trust (J.M., S.S., R.P.-L., A.O., N.T., D.B., Z.Z., R.F., D. Roda, R.E., G.A., J.S.B.), and University College London Hospital (U.M.), London, Queen's University, Belfast (S.J.), University of Leeds, Leeds (C.R.), Churchill Hospital, Oxford (A.P.), University of Liverpool, Liverpool (S.H.), Beatson West of Scotland Cancer Centre, Glasgow (R.J.), and Christie Hospital, Manchester (T.E.) - all in the United Kingdom; the University of Michigan, Ann Arbor (D. Robinson, Y.-M.W., X.C., L.P.K., F.Y.F., A.M.C.); Weill Cornell Medical College, New York (M.A.R.); and Thomas Jefferson University, Philadelphia (K.E.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1506859DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228595PMC
October 2015

Phosphorylation and SCF-mediated degradation regulate CREB-H transcription of metabolic targets.

Mol Biol Cell 2015 Aug 24;26(16):2939-54. Epub 2015 Jun 24.

Department of Medicine, Imperial College, London W2 1PG, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1091/mbc.E15-04-0247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571331PMC
August 2015

T-box factors: targeting to chromatin and interaction with the histone H3 N-terminal tail.

Pigment Cell Res 2007 Aug;20(4):279-87

Signalling and Development Laboratory, Marie Curie Research Institute, The Chart, Oxted, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0749.2007.00389.xDOI Listing
August 2007

Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.

Genes Dev 2006 Dec;20(24):3426-39

Signalling and Development Laboratory, Marie Curie Research Institute, Oxted, Surrey, RH8 0TL, United Kingdom.

View Article

Download full-text PDF

Source
http://www.genesdev.org/cgi/doi/10.1101/gad.406406
Publisher Site
http://dx.doi.org/10.1101/gad.406406DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698449PMC
December 2006

Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.

Cancer Res 2005 Mar;65(6):2260-8

Signaling and Development Laboratory, Marie Curie Research Institute, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-3045DOI Listing
March 2005

Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression.

Nature 2005 Feb;433(7027):764-9

Signalling and Development Laboratory, Marie Curie Research Institute, The Chart, Oxted, Surrey RH8 OTL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature03269DOI Listing
February 2005

Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin.

Mol Cell Biol 2004 Apr;24(7):2915-22

Signaling and Development Laboratory, Marie Curie Research Institute, The Chart, Oxted, Surrey RH8 0TL, United Kingdom.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC371132PMC
http://dx.doi.org/10.1128/mcb.24.7.2915-2922.2004DOI Listing
April 2004

Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor.

Cancer Res 2004 Mar;64(5):1669-74

Signalling and Development Laboratory, Marie Curie Research Institute, Oxted, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/canres/64/5/1669.f
Web Search
http://dx.doi.org/10.1158/0008-5472.can-03-3286DOI Listing
March 2004